Phase II Study of NALIRIFOX (Nanoliposomal Irinotecan + Oxaliplatin With Fluorouracil and Folinic Acid) in Advanced Unresectable Small Bowel Tumors
Latest Information Update: 17 Jun 2025
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Irinotecan (Primary) ; Oxaliplatin (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
Most Recent Events
- 10 Jun 2025 Planned initiation date (estimated date of first patient enrollment) changed from 1 May 2025 to 1 Jun 2025.
- 03 Apr 2025 Planned initiation date (estimated date of first patient enrollment) changed from 1 Mar 2025 to 1 May 2025.
- 03 Apr 2025 Status changed from not yet recruiting to recruiting.